A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
Achim Rothe,Stephanie Sasse,Max S. Topp,Dennis A. Eichenauer,Horst Hummel,Katrin S. Reiners,Markus Dietlein,Georg Kuhnert,Joerg Kessler, Carolin Buerkle,Miroslav Ravic,Stefan Knackmuss,Jens-Peter Marschner,Elke Pogge von Strandmann,Peter Borchmann,Andreas Engert Blood（2015）
AI 理解论文
溯源树
样例
